Martin Meyer

1.6k total citations
23 papers, 1.2k citations indexed

About

Martin Meyer is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Martin Meyer has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Infectious Diseases and 6 papers in Genetics. Recurrent topics in Martin Meyer's work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Amoebic Infections and Treatments (4 papers). Martin Meyer is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Amoebic Infections and Treatments (4 papers). Martin Meyer collaborates with scholars based in Germany, Switzerland and United States. Martin Meyer's co-authors include Ernst Wagner, Alexander Philipp, Reza Kazemi Oskuee, Claudia Schmidt, Manfred Ogris, Stefan Duscha, Erik C. Böttger, Tanja Matt, Dmitri Shcherbakov and Rashid Akbergenov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Martin Meyer

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Meyer Germany 17 927 215 171 122 111 23 1.2k
Zhijin Chen China 22 514 0.6× 83 0.4× 255 1.5× 77 0.6× 206 1.9× 51 1.2k
Liping Liu China 18 641 0.7× 93 0.4× 126 0.7× 73 0.6× 191 1.7× 39 1.5k
Ji‐Hyun Yeom South Korea 21 780 0.8× 213 1.0× 77 0.5× 30 0.2× 116 1.0× 58 1.2k
Wolfgang Zauner Austria 22 1.6k 1.7× 615 2.9× 290 1.7× 114 0.9× 191 1.7× 35 2.4k
Rodrigo V. Portugal Brazil 20 453 0.5× 88 0.4× 141 0.8× 49 0.4× 164 1.5× 53 992
David J. Sherman United States 11 553 0.6× 356 1.7× 71 0.4× 53 0.4× 457 4.1× 14 1.3k
G. Antoni Italy 16 579 0.6× 143 0.7× 119 0.7× 83 0.7× 54 0.5× 46 1.2k
Beate Thu Norway 12 339 0.4× 155 0.7× 133 0.8× 50 0.4× 172 1.5× 13 1.1k
Arik Makovitzki Israel 17 992 1.1× 115 0.5× 190 1.1× 46 0.4× 93 0.8× 25 1.6k
Teerapong Yata Thailand 21 452 0.5× 83 0.4× 145 0.8× 43 0.4× 136 1.2× 54 1.0k

Countries citing papers authored by Martin Meyer

Since Specialization
Citations

This map shows the geographic impact of Martin Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Meyer more than expected).

Fields of papers citing papers by Martin Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Meyer. The network helps show where Martin Meyer may publish in the future.

Co-authorship network of co-authors of Martin Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Meyer. A scholar is included among the top collaborators of Martin Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Meyer. Martin Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nehls, Sarah, Stephan Lorenzen, Martin Meyer, et al.. (2023). Genes differentially expressed between pathogenic and non-pathogenic Entamoeba histolytica clones influence pathogenicity-associated phenotypes by multiple mechanisms. PLoS Pathogens. 19(12). e1011745–e1011745. 1 indexed citations
2.
Meyer, Martin, Sarah Nehls, Tobias Holm, et al.. (2020). An Alcohol Dehydrogenase 3 (ADH3) from Entamoeba histolytica Is Involved in the Detoxification of Toxic Aldehydes. Microorganisms. 8(10). 1608–1608. 5 indexed citations
3.
Meyer, Martin, et al.. (2018). Trigger‐induced RNAi gene silencing to identify pathogenicity factors of Entamoeba histolytica. The FASEB Journal. 33(2). 1658–1668. 6 indexed citations
5.
Oishi, Naoki, Stefan Duscha, Martin Meyer, et al.. (2015). XBP1 mitigates aminoglycoside-induced endoplasmic reticulum stress and neuronal cell death. Cell Death and Disease. 6(5). e1763–e1763. 61 indexed citations
6.
Mathaes, Roman, et al.. (2014). Protein HESylation for half-life extension: Synthesis, characterization and pharmacokinetics of HESylated anakinra. European Journal of Pharmaceutics and Biopharmaceutics. 87(2). 378–385. 52 indexed citations
7.
Meyer, Martin, et al.. (2014). Head to Head Comparison of the Formulation and Stability of Concentrated Solutions of HESylated versus PEGylated Anakinra. Journal of Pharmaceutical Sciences. 104(2). 515–526. 24 indexed citations
8.
Meyer, Martin, et al.. (2014). In Vivo Efficacy of Apramycin in Murine Infection Models. Antimicrobial Agents and Chemotherapy. 58(11). 6938–6941. 23 indexed citations
9.
Perez‐Fernandez, Déborah, Dmitri Shcherbakov, Tanja Matt, et al.. (2014). 4′-O-substitutions determine selectivity of aminoglycoside antibiotics. Nature Communications. 5(1). 3112–3112. 66 indexed citations
10.
Matt, Tanja, Chyan Leong Ng, Kathrin Lang, et al.. (2012). Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proceedings of the National Academy of Sciences. 109(27). 10984–10989. 169 indexed citations
11.
Meyer, Martin, et al.. (2012). Regulation of Biosynthesis of Syringolin A, a Pseudomonas syringae Virulence Factor Targeting the Host Proteasome. Molecular Plant-Microbe Interactions. 25(9). 1198–1208. 10 indexed citations
12.
Matt, Tanja, Rashid Akbergenov, Martin Meyer, et al.. (2012). Structure-Activity Relationships among the Kanamycin Aminoglycosides: Role of Ring I Hydroxyl and Amino Groups. Antimicrobial Agents and Chemotherapy. 56(12). 6104–6108. 41 indexed citations
13.
Akbergenov, Rashid, Dmitri Shcherbakov, Tanja Matt, et al.. (2011). Molecular Basis for the Selectivity of Antituberculosis Compounds Capreomycin and Viomycin. Antimicrobial Agents and Chemotherapy. 55(10). 4712–4717. 30 indexed citations
14.
Meyer, Martin, et al.. (2009). Biosynthesis of the proteasome inhibitor syringolin A: the ureido group joining two amino acids originates from bicarbonate. BMC Biochemistry. 10(1). 26–26. 33 indexed citations
15.
Buyens, Kevin, Martin Meyer, Ernst Wagner, et al.. (2009). Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy. Journal of Controlled Release. 141(1). 38–41. 86 indexed citations
16.
Philipp, Alexander, Martin Meyer, & Ernst Wagner. (2008). Extracellular Targeting of Synthetic Therapeutic Nucleic Acid Formulations. Current Gene Therapy. 8(5). 324–334. 18 indexed citations
17.
Meyer, Martin, Alexander Philipp, Reza Kazemi Oskuee, Claudia Schmidt, & Ernst Wagner. (2008). Breathing Life into Polycations:  Functionalization with pH-Responsive Endosomolytic Peptides and Polyethylene Glycol Enables siRNA Delivery. Journal of the American Chemical Society. 130(11). 3272–3273. 224 indexed citations
18.
Meyer, Martin, Arkadi Zintchenko, Manfred Ogris, & Ernst Wagner. (2007). A dimethylmaleic acid–melittin‐polylysine conjugate with reduced toxicity, pH‐triggered endosomolytic activity and enhanced gene transfer potential. The Journal of Gene Medicine. 9(9). 797–805. 73 indexed citations
19.
Meyer, Martin & Ernst Wagner. (2006). pH-responsive shielding of non-viral gene vectors. Expert Opinion on Drug Delivery. 3(5). 563–571. 57 indexed citations
20.
Meyer, Martin & Ernst Wagner. (2006). Recent Developments in the Application of Plasmid DNA-Based Vectors and Small Interfering RNA Therapeutics for Cancer. Human Gene Therapy. 17(11). 1062–1076. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026